These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12417827)

  • 1. Molecular mechanisms of diabetic cardiovascular disease.
    Hupfeld CJ; Wong GA
    Prev Cardiol; 2002; 5(4):183-7. PubMed ID: 12417827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic stress: new triumphs and challenges to maintain vascular longevity.
    Maiese K
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):281-4. PubMed ID: 18327989
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and vascular disease.
    Garber AJ
    Diabetes Obes Metab; 2000 Nov; 2 Suppl 2():S1-5. PubMed ID: 11210239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes and coronaropathy].
    Pyörälä K
    Journ Annu Diabetol Hotel Dieu; 1988; ():259-71. PubMed ID: 3050226
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.
    McVeigh GE; Gibson W; Hamilton PK
    Diabetes Obes Metab; 2013 Mar; 15(3):198-203. PubMed ID: 22998614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPIRIN FOR PRIMARY PREVENTION IN PATIENTS WITH TYPE 2 DIABETES.
    Foster JG; Wood SK; Pfeffer MA; DeMets DL; Garber A; Hennekens CH
    Endocr Pract; 2018 Oct; 24(10):925-927. PubMed ID: 29975578
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose control in type 2 diabetes: still worthwhile and worth pursuing.
    Kahn SE
    JAMA; 2009 Apr; 301(15):1590-2. PubMed ID: 19366780
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin for primary prevention of cardiovascular events in people with diabetes.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic cardiovascular disease: getting to the heart of the matter.
    Peterson LR; McKenzie CR; Schaffer JE
    J Cardiovasc Transl Res; 2012 Aug; 5(4):436-45. PubMed ID: 22639341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the pathogenesis of type 2 diabetes may explain the stronger impact of diabetes on atherosclerotic heart disease in women.
    Mauvais-Jarvis F
    J Diabetes Complications; 2019 Jun; 33(6):460-461. PubMed ID: 30981432
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: a matched-paired retrospective analysis using coronary angiography as the diagnostic tool.
    Fallow GD; Singh J
    Mol Cell Biochem; 2004 Jun; 261(1-2):263-9. PubMed ID: 15362512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus.
    Baldwin MD
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S2-12. PubMed ID: 21813732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery calcium: a clue to the enigma of tight glycemic control and cardiovascular disease?
    Bertoni AG; Kitzman DW
    Diabetes; 2009 Nov; 58(11):2448-9. PubMed ID: 19875621
    [No Abstract]   [Full Text] [Related]  

  • 16. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
    Nadal JF; Gutiérrez PC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?].
    Benhamou Y; Lévesque H
    Rev Med Interne; 2009 Dec; 30(12):1001-3. PubMed ID: 19833416
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in preventing cardiovascular complications in type 2 diabetes in primary care.
    Ubink-Veltmaat LJ; Bilo HJ; Groenier KH; Rischen RO; Meyboom-de Jong B
    Eur J Gen Pract; 2005 Mar; 11(1):11-6. PubMed ID: 15841058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do not forget that type 2 diabetes does not only expose to cardiovascular complications.
    Halimi S
    Diabetes Metab; 2014 Jun; 40(3):167-8. PubMed ID: 24751987
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of tight blood glucose control in diabetes.
    Andersson DK
    Scand J Prim Health Care; 1995 Jun; 13(2):81-2. PubMed ID: 7569482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.